NCT01317914

Prospective Study of Undiagnosed Celiac Disease

Epidemiology of Celiac Disease: A Prospective Study of Undiagnosed Celiac Disease in the Community

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 31 (actual)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 60 Years
• Healthy volunteers: Not accepted

Summary

Direct benefits to the participants, who are diagnosed with celiac disease may be substantial and could include lessening or prevention of GI symptoms, correction of biochemical abnormalities and reduction in risk for malignancies or bone disease which are most common in untreated celiac disease. However, the precise benefit is unknown and the motivation for this proposed study. If these individuals have a positive celiac serology test at the present time there is a high likelihood that they may have celiac disease.

Conditions

• Celiac Disease

Interventions

Type	Name	Description
OTHER	Dietary instruction	Subjects subsequently diagnosed with celiac disease will have gluten-free diet instructions given by registered dietitian experienced in the gluten-free diet. Subjects will have follow-up in 3 months time from initial instruction to verify compliance.

Timeline

• Start date: 2010-07-01
• Primary completion: 2012-04-01
• Completion: 2012-04-01
• First posted: 2011-03-17
• Last updated: 2017-10-02

Locations

1 site across 1 country: United States